Recurrent/ Advanced Stage Endometrial Cancer Patients

1 clinical trials · Condition

Record	Firm	Date
An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients (NCT04885413)	Sun Yat-sen University	2021-07-01

Every clearance here is in the API, with alerts when new ones post.